期刊文献+

转染癌胚抗原基因的人树突状细胞疫苗表达的研究

The Expression of Dendritic Cell Transfected with Plasmid Carcinoembryonic Antigen
下载PDF
导出
摘要 目的 探索使用质粒转导制备转基因DCs疫苗的方法。方法 采用细胞因子rhIL 4和rhGM CSF诱导培养法制备人外周血树突状细胞 ,用Lipofectine向人DCs转染含人CEA真核表达质粒。结果 转染组DCs培养上清CEA含量明显高于未转染组培养上清CEA含量。 Aim To prepare the vaccine of DCs transfected with plasimid carcinoembryonic antigen.Methods DC were generated from human peripheral blood.The plasmid encoding human carcinoembryonic antigen was transfected with Lipofectamine into human DCs.Results CEA expression level in the DC (pcDNA3-CEA +) culture supernatant is higher than in the DCs culture supernatant.Conclusions DCs transfected with human DC DNA3 CEA can endogenously express CEA.
出处 《河南肿瘤学杂志》 2003年第3期164-165,F003,共3页 Henan Journal of Oncology
关键词 癌胚抗原 人树突状细胞 疫苗 基因转染 脂质体 细胞因子 dendritic cell,carcinoebryonic antigen,gene transfection,lipofectamine
  • 相关文献

参考文献7

  • 1黄幼田,赵明耀,杨洪艳,郑智敏,马俊芬,汤黎明,董子明.小鼠内源性抗原提呈树突状细胞疫苗的抗瘤作用[J].郑州大学学报(医学版),2002,37(2):133-136. 被引量:3
  • 2Huang AYC, Golumber P, Ahmadzadeh M, et a2. Role of bone marrow derived cells in presenting MHC class I-restricted tumor antigens [ J ].Scince 1998,264:961 - 965.
  • 3Brown RD, Pope B, Nuray A, et al. Dendritic cells from patients with meloma are vnumerically normal but functionally defective as they fail to upregulate CD80 (B7-1) expression by transforming growth factor-batal and interleukin- 10[ J ]. Blood 2001,98(10) :2992 - 2298.
  • 4Ardavin C, I artinez del Hoyo G, Iartin P, et al. Origin and differentiation of dendritic cells[J] .Trends Immunol 2001,22(2) :691 - 700.
  • 5Aradavin C,I artinez del Hoyo G,Iartin P, et al .Origin and differentiation of dendritic cells[J] .Trends Immunol 2001,22(2) :691 - 700.
  • 6David Boczkowski, Smita K., Nair, et al. Induction of tumor immuity and cytotoxic Tlymphocyte responses using dendritic cell transfeted with messenger RNA amplified from tumor cells [ J ]. Cancer Research. 2000, 60 :1028- 1034.
  • 7Nishioka Y, Hua W, Nishimum N, et al. Genetic modification of dendritic cells and its application for cancer immunotherapy [ J ]. J Med Invest 2002,49(1 -2):7- 17.

二级参考文献2

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部